Loading patent…
AssigneeL'Air Liquide, Societe Anonyme pour I'Etude et I'Exploitation des Procedes Georges Claude
InventorsBaptiste BESSIERE, Jan Pype, Guy Simonnet
Estimating the term…
The invention relates to a gaseous inhalable medicament containing xenon or N2O as active ingredient for use by inhalation for preventing and/or for treating neuropathic pain or pains caused by at least one cancer chemotherapy substance administered to a patient suffering from cancer, in particular a patient suffering from breast cancer, lung cancer, ovarian cancer, prostate cancer, colon cancer, rectal cancer or a gastric cancer or cancer of the upper aerodigestive tracts. The cancer chemotherapy substance contains one or more compounds chosen from platinum salts, taxanes, alkaloids, thalidomide and bortezomib, in particular paclitaxel, docetaxel or oxaliplatin. The effective volume proportion of nitrous oxide or of xenon is between 5 and 70%.
A method of treating a neuropathic pain in a cancer patient undergoing chemotherapy, the method comprising the step of administering a gaseous inhalable medicament containing xenon or N2O as active ingredient by inhalation to thereby prevent and/or for treat the neuropathic pain, wherein the neuropathic pain is induced by at least one cancer chemotherapy substance administered to the patient suffering from cancer, said cancer chemotherapy substance being chosen from platinum salts, taxanes, alkaloids, thalidomide and bortezomib.
Dependencies are inferred from the claim text.